Phase 4
Completed N=34
Octylseal Surgical Adhesive in General Surgery
Source: ClinicalTrials.gov NCT01514383 ↗Enrolled (actual)
34
Serious AEs
0.0%
Results posted
May 2019
Primary outcomePrimary: Wound Length Closure — 28.97; 21.00 milimeters
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to evaluate how surgical adhesive is used.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Wound Length Closure |
28.97; 21.00 | — |
| SECONDARY Number of Participants With a Score of "0" (No Hurt) on the Pain Rating Scale |
34 | — |
Eligibility Criteria
Inclusion Criteria
- Candidate for use of a topical surgical skin adhesive
Exclusion Criteria
- Subjects with know sensitivity to topical surgical tissue adhesive products or degrading products (cyanoacrylates or formaldehyde)
- Subjects with a history of keloid formation, hypotension, insulin dependent diabetes mellitus, blood/clotting disorders, peripheral vascular diseases or hypertrophy history
- Subjects who present with a contraindications for product usage as per labeling
- A wound with evidence of active infection or gangrene or wounds of decubitus etiology
- Mucosal surfaces or across mucocutaneous junctions or skin that might be exposed to bodily fluids or with dense natural hair
- Subjects with known hypersensitivity to cyanoacrylate or formaldehyde
Data sourced from ClinicalTrials.gov (NCT01514383). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.